Bromhexine is contraindicated in children under 2 years of age
Based on the available evidence, bromhexine should not be used in children younger than 2 years old, and its routine use is not recommended even in older children and adolescents with bronchiectasis.
Age-Specific Contraindications
The most recent and highest-quality guideline evidence from the European Respiratory Society (2021) explicitly states that bromhexine should not be used routinely in children and adolescents with bronchiectasis due to concerns about adverse effects and lack of demonstrated efficacy 1. While this guideline addresses bronchiectasis specifically, the safety concerns extend to general pediatric use.
Supporting Evidence for Age Restrictions
The broader context of cough and cold medications in young children provides critical safety framework:
Children under 6 years: The FDA's Nonprescription Drugs and Pediatric Advisory Committees recommended in 2007 that OTC cough and cold medications should not be used in children below 6 years of age due to potential toxicity and lack of established efficacy 2
Children under 2 years: Multiple pharmaceutical companies voluntarily removed cough and cold medications for children under 2 years from the OTC market in 2007 following safety concerns 2
Clinical Evidence Against Bromhexine Use
Studies examining bromhexine's efficacy show concerning patterns:
- In adult studies with chronic bronchitis or bronchiectasis, bromhexine was inactive in modifying cough in three studies and showed increased adverse events (OR 2.93) 3
- The European Respiratory Society panel expressed concern about potential adverse effects, leading to their recommendation against routine use 1
- Even when combined with antibiotics in pneumonia treatment, bromhexine showed no improvement in cough outcomes 4
Practical Clinical Guidance
Absolute contraindication: Children under 2 years of age should never receive bromhexine
Strong recommendation against use: Children 2-6 years should generally avoid bromhexine given the lack of safety data and efficacy in this age group
Not recommended for routine use: Even in children over 6 years and adolescents, bromhexine should not be used routinely 1
Important Caveats
The evidence base specifically addressing bromhexine's age contraindications is limited, but the safety concerns for cough medications in young children are well-established. The risk-benefit ratio clearly favors avoiding bromhexine in young children, particularly given the availability of safer alternatives and the generally self-limited nature of most respiratory conditions requiring mucolytic therapy.